| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/17/2001 | EP1067893A2 Human galactosyl transferases |
| 01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
| 01/17/2001 | EP0730590B1 isoxazoline and isoxazole fibrinogen receptor antagonists |
| 01/17/2001 | EP0490919B1 Cytoprotective compounds bearing unsaturated hydrocarbon groups having 16 to 20 carbon atoms |
| 01/17/2001 | CN1280613A Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 01/17/2001 | CN1280572A Inhibiting platelet derivative growth factor and/or quinoline and quinowoline compounds of P56lek tyrosinkinase |
| 01/17/2001 | CN1280568A Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 01/17/2001 | CN1280560A Adamantane derivatives |
| 01/17/2001 | CN1280126A Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 01/17/2001 | CN1280125A Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation |
| 01/17/2001 | CN1280003A Medicine for curing lumbago |
| 01/17/2001 | CN1279978A Ginkgo and gastrodia taber capsule |
| 01/17/2001 | CN1279977A Chinese medicine preparation for curing rheumatic arthritis and its preparing method |
| 01/17/2001 | CN1279969A Anti-inflammation analgesic for chinese medicine osmosis therapy and its preparing technology |
| 01/17/2001 | CN1060768C Pyrazoles and pyrazolopyrimidines |
| 01/16/2001 | US6175021 Human non-pancreatic secretory phospholipase a2 (spla2); inhibits release of arachidonic acid to treat septic shock; ((3-(2-amino-1,2-dioxoethyl)-2-methyl-1-(phenylmethyl)-1h-indol-4 -yl)oxylacetic acid, for example |
| 01/16/2001 | US6174994 7TM receptor (H2CAA71) |
| 01/16/2001 | US6174993 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 01/16/2001 | US6174896 Quinuclidine derivatives and medicinal composition thereof |
| 01/16/2001 | US6174895 1-aryl-3-arylmethyl-1,8-naphthyridin-4(1H)-ones |
| 01/16/2001 | US6174887 Amide compounds and use of the same |
| 01/16/2001 | US6174883 3-substituted-2-oxindoles derivatives |
| 01/16/2001 | US6174873 Oral administration of adenosine analogs |
| 01/16/2001 | US6174676 Cytokine-stress- and oncoprotein-activated human protein kinase kinases |
| 01/16/2001 | CA2314008A1 2-benzimidazolylamine compounds as orl1-receptor agonists |
| 01/16/2001 | CA2200192C Amidino and guanidino substituted inhibitors of trypsin-like enzymes |
| 01/16/2001 | CA2140345C Anti-inflammatory compounds for ophthalmic use |
| 01/14/2001 | CA2277407A1 Pharmaceutical tablet comprising an nsaid and misoprostol |
| 01/11/2001 | WO2001002866A1 Diagnostics and therapeutics for arterial wall disruptive disorders |
| 01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002567A1 16405 receptor, a g-protein coupled receptor |
| 01/11/2001 | WO2001002540A2 Adenoviral vectors for treating disease |
| 01/11/2001 | WO2001002439A1 Neovascular-targeted immunoconjugates |
| 01/11/2001 | WO2001002437A1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 01/11/2001 | WO2001002403A1 METHOD FOR PREPARING SUBSTITUTED [1,4]DIAZEPINO[6,7,1-hi]INDOL-4-ONES |
| 01/11/2001 | WO2001002399A1 Substituted purine derivatives as inhibitors of cell adhesion |
| 01/11/2001 | WO2001002398A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 01/11/2001 | WO2001002388A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | WO2001002387A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
| 01/11/2001 | WO2001002381A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/11/2001 | WO2001002369A2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2001 | WO2001002362A1 Azo amino acid derivatives for the treatment of neurological diseases |
| 01/11/2001 | WO2001002359A1 Heterocyclic compounds and medicinal use thereof |
| 01/11/2001 | WO2001002018A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 01/11/2001 | WO2001002015A1 Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs |
| 01/11/2001 | WO2001002011A1 REMEDIES FOR DISEASES CAUSED BY PTH OR PTHrP |
| 01/11/2001 | WO2001001989A1 Novel pharmaceutical combination with analgesic action containing paracetamol and buspirone |
| 01/11/2001 | WO2001001988A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | WO2001001985A1 Antiviral therapy |
| 01/11/2001 | WO2001001983A1 A synergistic combination: gabapentin and pregabalin |
| 01/11/2001 | WO2001001981A1 Vegf receptor antagonists |
| 01/11/2001 | WO2001001976A2 Composition comprising an extract of perna canaliculus, methylsulfonylmethane and glucosamine |
| 01/11/2001 | WO2001001970A2 New uses potassium channel openers, such as the treatment of epilepsy |
| 01/11/2001 | WO2001001963A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001962A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001959A1 Ophthalmic compositions in form of aqueous gels |
| 01/11/2001 | WO2001001958A1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip |
| 01/11/2001 | WO2001001940A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 01/11/2001 | WO2001001939A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 01/11/2001 | WO2001001932A2 Oligosaccharide aldonic acids and their topical use |
| 01/11/2001 | WO2001001749A2 FVIIa ANTAGONISTS |
| 01/11/2001 | WO2001001748A2 Peptide compounds that bind her2 |
| 01/11/2001 | WO2000061608A3 Low-molecular inhibitors of complement proteases |
| 01/11/2001 | WO2000061189A3 Water-soluble compositions of bioactive lipophilic compounds |
| 01/11/2001 | WO2000059904A3 Compounds and methods to treat cardiac failure and other disorders |
| 01/11/2001 | WO2000059515A3 Immunomodulating polymers |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/11/2001 | WO2000053596A3 Imidazole compounds as histamine h3 ligands |
| 01/11/2001 | WO2000048581A3 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases |
| 01/11/2001 | DE19932315A1 Benzoylpyridazine Benzoylpyridazine |
| 01/11/2001 | DE19930177A1 Intermolekular assoziierende Verbindungen und diese umfassende Aggregate Inter-molecular compounds and associating this comprehensive aggregates |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2377771A1 Heterocyclic compounds and medical use thereof |
| 01/11/2001 | CA2377381A1 Neovascular-targeted immunoconjugates |
| 01/11/2001 | CA2376707A1 Process for the preparation of substituted ¬1,4|diazepino¬6,7,1-hi|indol-4-ones |
| 01/11/2001 | CA2376673A1 Substituted purine derivatives as inhibitors of cell adhesion |
| 01/11/2001 | CA2376657A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | CA2376513A1 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | CA2375157A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | CA2373953A1 A synergistic combination: gabapentin and pregabalin |
| 01/11/2001 | CA2373885A1 Therapeutic agent for diseases caused by pth or pthrp |
| 01/11/2001 | CA2373882A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | CA2373879A1 Antiviral therapy |
| 01/11/2001 | CA2373877A1 Novel pharmaceutical combination with analgesic action containing paracetamol and buspirone |
| 01/11/2001 | CA2373735A1 Fviia antagonists |
| 01/11/2001 | CA2373352A1 Adenoviral vectors for treating disease |
| 01/10/2001 | EP1067136A1 New peptide derivatives |
| 01/10/2001 | EP1067130A1 Triazolo derivatives and chemokine inhibitors containing the same as the active ingredient |
| 01/10/2001 | EP1066833A2 Cryopreserved cells, system for supplying cells on commission, and preventive or remedial method of infections or cancers |
| 01/10/2001 | EP1066377A1 Methods for prevention and treatment of cancer |
| 01/10/2001 | EP1066323A1 Treatment and prevention of vascular disease |
| 01/10/2001 | EP1066319A1 Production methods and uses of a retrovirus |
| 01/10/2001 | EP1066316A1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 01/10/2001 | EP1066315A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |
| 01/10/2001 | EP1066290A1 PYRROLO[1,2-a]PYRAZINE sPLA 2 INHIBITOR |
| 01/10/2001 | EP1066286A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 01/10/2001 | EP1066273A1 Metalloproteinase inhibitors |
| 01/10/2001 | EP1066271A1 Thiocarboxamide derivatives and their use as inhibitors of alpha-4 integrins |
| 01/10/2001 | EP1066257A2 Heterocylic classes of compounds for the modulating tyrosine protein kinase |